Related Experiment Videos
Adenosine 5'-triphosphate axis in obstructive airway diseases
Amir Pelleg1, Edward S Schulman
1Department of Medicine, MCP Hahnemann University, Philadelphia, Pennsylvania 19102-1192, USA. pellega@drexel.edu
American Journal of Therapeutics
|September 19, 2002
Summary
Endogenous purine nucleotides like adenosine 5'-triphosphate (ATP) are implicated in obstructive airway diseases. Targeting ATP signaling pathways offers a promising new therapeutic strategy for conditions such as asthma.
Area of Science:
- Pulmonary Medicine
- Cellular Biology
- Pharmacology
Background:
- Current treatments for obstructive airway diseases, including asthma, are suboptimal and can cause systemic side effects.
- Understanding the pathophysiology of these conditions has advanced, but therapeutic breakthroughs remain limited.
Purpose of the Study:
- To explore the role of endogenous purine nucleotides, specifically adenosine 5 '-triphosphate (ATP), in the pathophysiology of obstructive airway diseases.
- To identify ATP signal transduction as a potential therapeutic target for these disorders.
Main Methods:
- Review of recent studies investigating the role of ATP in relevant cell types.
- Analysis of ATP's mechanistic involvement in mast cells, eosinophils, dendritic cells, and neurons.
Main Results:
- Endogenous purine nucleotides, particularly ATP, play a mechanistic role in obstructive airway diseases.
- ATP influences key cell types involved in the inflammatory and neural pathways of these diseases.
Conclusions:
- Pharmacologic modulation of ATP signal transduction in relevant cells presents an attractive new therapeutic target.
- Targeting ATP pathways may lead to improved treatment options for obstructive airway diseases and asthma.